Blog | HemaCare

Therapy Using Stem Cells Reduces Deaths from End-Stage Heart Failure

May 18, 2016 1:00:52 PM / by Karina Palomares posted in Bone Marrow, Cardiovascular Disease, Stem Cell Therapy, Stem Cells

0 Comments

Results of a phase II clinical trial show that the outcomes of end-stage heart failure can be significantly improved using stem cells from a patient’s bone marrow.

Heart failure affects approximately 5 million people in the United States, with almost 500,000 new diagnoses each year. Despite advances in treatment to prevent or minimize cardiovascular disease, the restoration of function to a damaged heart remains a major challenge. Since the heart has limited regenerative capacity, transplants are often necessary for cases of end-stage heart failure. Stem cells have the ability to home to damaged tissue and enhance regeneration and remodeling of scar tissue. Thus, therapies using stem cells may potentially lead to more effective treatments for patients with end-stage heart disease.

Read More

An Alternative to Bypass Surgery: a Gene Silencer that Induces Anti-Inflammatory Macrophages and Prevents Atherosclerosis.

Jan 25, 2016 1:00:40 PM / by Dalia Gaddis posted in Cardiovascular Disease, Macrophages, Regulatory T Cells, Basic Research

0 Comments

Researchers find a microRNA that can alter macrophages from pathogenic M1 to anti-inflammatory M2 and protects against atherosclerosis.

We all know someone who has gone through a coronary artery bypass graft or, as commonly known, a bypass surgery. It starts with too much fat and cholesterol accumulating in and narrowing the arteries and ends with a relatively complicated surgical procedure where one or more arteries in the heart get replaced by another coming from the patient’s chest or leg. While the mortality rate due to the procedure is only at 2-4%, there are multiple risks involved with the surgery, and these risks increase further with additional complications, such as diabetes, obesity, or poor general health. It is estimated that in the U.S. more than 500,000 patients undergo a coronary bypass surgery with a rough cost of 30 billion dollars each year1.

Read More

Stem Cell Quandry: Which Precursor is Best for Ailing Hearts?

Nov 23, 2015 1:00:13 PM / by Shweta posted in Cardiovascular Disease, Cell Therapy, Regenerative Medicine, Stem Cell Therapy, Stem Cells, Basic Research

0 Comments

Researchers study alternatives to bone marrow-derived stem cells for post-heart attack tissue repair

Stem cell-based therapy is emerging as a promising modality to rejuvenate a dying heart after heart failure, a leading cause of morbidity and mortality worldwide. Largely, clinical trials have used bone marrow-derived stem cells to improve the cardiac performance in ailing hearts. Unfortunately, bone marrow-derived stem cells could not help patients with this devastating disease except for very minor temporary improvements, which generally go away with the time.

Read More

Stem Cells For Heart Disease: A New Chapter. Part 2

Oct 1, 2014 1:00:57 PM / by James Sanchez posted in Cardiovascular Disease, Stem Cells, Basic Research

0 Comments

Is a dawn of a new era of stem cell treatment for heart disease on its way? Image credit: http://commons.wikimedia.org/wiki/
Read More

Stem Cells for Healthy Hearts? Part 1

Sep 10, 2014 1:00:35 PM / by James Sanchez posted in Cardiovascular Disease, Regenerative Medicine, Stem Cells

0 Comments

The search for curative therapies for heart disease has prompted a look at stem cells as a possible solution. What do the first clinical trials tell us?

Read More

      Subscribe Here!

      Posts by Topic

      see all

      Recent Posts